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INTRODUCTION
Nasal polyposis (NP) is a chronic inflammatory disease of the mucous membranes in the nose and paranasal sinuses and is estimated to affect 31 million Americans. [1, 2] They are generally considered as a result of extreme nasal mucosal edema induced by long-term recurrent inflammation. Epithelial hyperplasia, basement membrane thickening, eosinophilic infiltration, mast cell degranulation, inflammatory cells infiltration, stromal fibrosis, and nasal mucosal edema can be seen in NPs. Chemical mediators that are are produced by inflammatory cells causes hyperplasia and epithelial cell proliferation and prolong the life span of eosinophils. [3] [4] [5] [6] Cell proliferation and apoptosis have become a new focus in NP pathogenesis research. The presence of eosinophils in the polypoid tissue reduces the apoptosis index. [7] [8] [9] Many studies have shown that antineoplastic agents, steroids, and intranasal phototherapy used for therapeutic purposes induce apoptosis. [10] [11] [12] Akt family proteins are survival factors and activation of the PI3K/c-Akt pathway promotes cell survival. [13] [14] [15] Estrogen acts as a key regulator in cell growth and differentiation. [16] Many studies have shown that there is a relationship between estrogen receptors (ERs) and sinonasal malignancies. [17] [18] [19] [20] Like the uncertainties in NP ethiopathogenesis, the precise apoptotic pathway in NP remains unclear.
In this study, we aimed to evaluate the expression of ERs and its association with Akt signaling pathway in NP, which has not been studied previously in the literature.
MATERIALS AND METHODS

Patients and methods
This study has been submitted to and approved by the clinical research ethics committee. Patients with allergic fungal sinusitis or asthma were not included in the study. The recruited patients neither used steroid (systemic or topical) nor have taken any other systemic medication at least 4 weeks before the operation. About 20 NP samples were obtained from patients undergoing endoscopic polyp biopsy for diagnostic purposes and 15 turbinate samples were collected from patients undergoing turbinate resection (in patients with compensatory turbinate hypertrophy due to nasal septal deviation). The excised NP tissues appear as semitranslucent, gelatinous, and macroscopically pale pink or white in color. Turbinate resection samples were used as control group.
All samples were fixed in 10% formalin for 24 h and processed for embedding in paraffin using routine protocol and cut with a rotary microtome to obtain sections of 5 µm thick (Leica RM2245) to be stained with hematoxylin and eosin (H and E). Also additional sections were used for immunohistochemical staining. Tissue samples were stored at 60°C overnight and then were deparaffinized in xylene for 30 minutes. After dehydration of the sections with ethanol, they were washed with distilled water. The tissues were then treated with 2% trypsin (ab970, Abcam, Cambridge, UK) at 37°C for 15 minutes and incubated in 3% H 2 O 2 solution for 15 minutes to inhibit endogenous peroxidase activity. Then, sections were incubated with antiER-α primary antibody (sc-787, Santa Cruz Biotechnology, Inc, California, USA) and anti Akt (sc-377457, Santa Cruz Biotechnology, Inc, California, USA) primary antibodies in a 1/100 dilution for 18 hours at +4°C. They were then given an additional three 5-washes in PBS, followed by incubation with biotinylated IgG and administration of streptavidin peroxidase (Histostain Plus kit cat no: 85-9043, Invitrogen). After washing the secondary antibody with PBS three times for 5 minutes, the sections were stained with DAB substrate system containing diaminobenzidine (DAB-plus substrate kit, Invitrogen) to detect the immunoreactivity and then stained with Mayer's hematoxylin (72804E, Microm, Walldorf, Germany) for counterstaining. The specimen was covered with mounting medium (Clear Mount, Mounting Medium Ref: 008110 Invitrogen, USA). Control sections were processed in an identical manner, but the primary antibody incubation step was omitted. Two observers blinded to clinical information evaluated the staining scores independently with light microscopy (Olympus BX-43, Tokyo, Japan). Staining intensity was graded as negative (-), mild (+), moderate, (++) and intense (+++), respectively.
Statistical analysis
Mann-Whitney-U test was applied to evaluate the statistical signification between ER and Akt expression in NP and control groups. P < 0.05 was regarded as significant.
RESULTS
The mucosa and submucosal connective tissue was seen normally in control group in H and E staining [ Figure 1a ]. The mucosa and submucosal tissue has a hyperemic appearance and there was a lot of inflammatory cells in submucosal connective tissue and also around the glandular epithelium in NP group [ Figure 1b] .
ER was expressed strongly in NP tissue where they were detected in epithelial and inflammatory cells and submucosal glands. On the other hand, ER was expressed mildly in control group. The difference of ER expression between the two groups was statically significant (P < 0.001). ER was intensely expressed in NP [ Figure 1c ]. ER was expressed mildly in control group [ Figure 1d ].
AKT was expressed strongly in NP where they were detected in epithelial and inflammatory cells and submucosal glands. Akt was expressed mildly in control group. The differences of Akt expression between the two groups were statically significant (P < 0.001). AKT was intensely expressed in NP [ Figure 1e ]. AKT was expressed mildly in control group [ Figure 1f ].
To score ER and Akt staining, three high-power fields were selected and evaluated by two observers blindly.
Immunolabeling intensity of ERs and Akt was presented in Table 1 .
DISCUSSION
NP is featuring inflammatory cell infiltration, eosinophilic infiltration, goblet cell hyperplasia, and modifications of epithelial differentiation and tissue remodeling including basement membrane thickening, focal fibrosis and edema, gland modifications, and extracellular matrix (ECM) accumulation. [1, 21] The eosinophils and the structural polyp cells produce cytokines that prolong the life span of eosinophils and improve their presence in the polypoid tissue, thus lowering the apoptosis index of these cells. [7, 8] In this study, we observed that both eosinophils and inflammatory cells are concentrated in the subepithelial region and around the secretory glands [ Figure 1b and c].
Cell proliferation, apoptosis, and apoptotic signal pathways have an important role in NP pathogenesis. There have been many studies supporting this theory. In a study Lee et al. showed that vascular endothelial growth factor in cases of chronic sinusitis with NP was linked to the induction of cell proliferation and inhibition of apoptosis of the epithelial cells. [22] Increased epithelial cell proliferation can describe NP etiology. Actually many agents were applied the NP patients for therapeutic purpose in order to induce the apoptosis. Cho et al. showed a significant increase in the active forms of caspase-8, caspase-9, and caspase-3 in NP treated with methotrexate, whereas in NPs treated with methotrexate, the expression of the phosphorylated form of Akt is significantly lower than that of untreated NPs. [10] This finding supports the increase in Akt expression in the current study. Chen et al. showed the relationship between PI3K/Akt signaling pathway and IL 6 expression and they observed PI3K/ Akt expression to be high in chronic rhinosinusitis. [23] In this study, we observed that the Akt expression, an anti-apoptotic pathway, was higher in NP group compare to control group. Akt expression was detected in epithelial cells, secretory glands, and inflammatory cells [ Figure 1e and f].
Estrogen acts as a key regulator in cell growth and differentiation. [13] [14] [15] [16] Dong et al. suggested that estradiol has a specific role in the development of NP. [3] They observed a high expression of E2 receptors. In this study we observed ER expression intensely and confirmed their study. Estrogen promotes cell survival, but it is not known whether Akt mediates these effects of estrogen. The expression of ER and Akt was increased significantly indicating that ER might be regulated by Akt in breast cancer. [24] [25] [26] [27] As a result of their study, Gil et al. reported that they have proposed new approaches to combine PI3K/Akt/mTOR pathway inhibitors with endocrine therapy for improved clinical outcomes in breast cancer. [24] In this study, increased Akt expression in NP group could alternatively be treated with Akt inhibitors and Akt inhibitors treatment may bring new approach in NPs.
In this study, we aimed to evaluate ER and Akt expression, which had not been observed before in NP tissues. We observed a high expression of Akt and ER in NP, on the other hand there was a mild expression of Akt and ER in control group. Therefore, the expression of ER and Akt might be important factors in NP pathogenesis. Pezato et al. and Berger et al. reported that the inferior turbinate tissues have a different mechanical and histological properties than the middle turbinate tissue and suggest that researchers must be avoided to use the inferior turbinate resections as a control of NPs. [28, 29] In our study, we evaluated this tissue immunohistochemically and observed that ER and Akt were expressed intensely in the NP mucosa, submucosal connective tissue and glandular epithelium, but they were expressed mildly in control group, indicating that further studies could be performed on this tissue.
Increasing evidence in recent years indicates that NPs undergo abnormal apoptosis and proliferation. Eosinophils exhibit low apoptosis. In this study, we observed extensive infiltration of eosinophils that can explain low apoptosis index in NPs. This explains the increase in Akt expression in NPs. The results of our study suggest that there was a signal that the effect of ER in the NP was regulated by Akt and inhibition of Akt signaling pathway may cause a new approach in NP treatment. 
CONCLUSION
Expression of Akt and ER in
